IL-4

IL-4 Overview

English NameInterleukin-4Approved Drugs2
Drugs in Clinical Trials7Target SynonymMGC79402,B-cell stimulatory factor 1,Lymphocyte stimulatory factor 1,IL4,Interleukin 4,B_cell Stimulatory Factor 1,B Cell Growth Factor 1,Binetrakin,Pitrakinra,BSF-1,IL-4,Interleukin 4 Variant 2,BCGF-1,BCGF1,BSF1,Interleukin-4
Highest Development StageApproved
English NameInterleukin-4
Target SynonymMGC79402,B-cell stimulatory factor 1,Lymphocyte stimulatory factor 1,IL4,Interleukin 4,B_cell Stimulatory Factor 1,B Cell Growth Factor 1,Binetrakin,Pitrakinra,BSF-1,IL-4,Interleukin 4 Variant 2,BCGF-1,BCGF1,BSF1,Interleukin-4
Approved Drugs2
Drugs in Clinical Trials7
Highest Development StageApproved

IL-4 Product List

  • Product Category

    Protein (11)Kits (5)

  • Product Status

    Launched (16)

  • Species

    Human (10)Mouse (3)Cynomolgus (3)

  • Tag

    Tag Free (3)His Tag & Avi Tag (3)His Tag (3)Fc Tag (2)- (5)

  • Conjugate

    Unconjugated (8)Biotin-labeled (3)- (5)

IL-4 Background

Interleukin-4, is a cytokine that induces differentiation of naive helper T cells (Th0 cells to Th2 cells). In the presence of IL-4 and IL-13, cytokines that are produced in a Th-2 type response, particularly during allergy and parasitic infections, macrophages become differentially activated, And this cytokine is a ligand for interleukin 4 receptor. The interleukin 4 receptor also binds to IL13, which may contribute to many overlapping functions of this cytokine and IL13. STAT6, a signal transducer and activator of transcription, has been shown to play a central role in mediating the immune regulatory signal of this cytokine. Recently, researcher found that the cytokine IL-4 plays a key role in development of innate CD8+ T cells in the thymus of several gene-deficient mouse strains, including Itk, KLF2, CBP and Id3, without previous exposure to antigen.

IL-4 Synonyms

IL4,BCGF1,BSF1

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
EblasakimabMK-6105; ASLAN-004; CSL-334Phase 2 ClinicalCsl Ltd, Merck Sharp & Dohme CorpDermatitis, Atopic; Hypersensitivity
Details
Dectrekumab/VAK-694QBX-258Phase 2 ClinicalNovartis Pharma AgLymphedema; Asthma
Details
OCH-NCNP1OCH-NCNP1Phase 2 ClinicalKeio UniversityMultiple Sclerosis; Crohn Disease
Details
PF-07264660PF-07264660Phase 2 ClinicalPfizer IncDermatitis, Atopic
Details
PF-07275315PF-07275315Phase 2 ClinicalPfizer IncDermatitis, Atopic
Details
AUP1602-CAUP-16; AUP1602-CPhase 2 ClinicalAurealisDiabetic Foot; Ulcer
Details
KBL-693KBL-693Phase 1 ClinicalKobiolabsAsthma
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
DupilumabSAR-231893; REGN-668ApprovedSanofi, Regeneron Pharmaceuticals IncDupixent, 达必妥United StatesDermatitis, AtopicRegeneron Pharmaceuticals Inc2017-03-28Pulmonary Disease, Chronic Obstructive; Sleep Apnea Syndromes; Sinusitis; Asthma; Colitis, Ulcerative; Duodenitis; Pemphigoid, Bullous; Neurodermatitis; Urticaria; Prurigo; Keloid; Conjunctivitis, Allergic; Paranasal Sinus Diseases; Scleroderma, Localized; Keratoconjunctivitis; Asthma, Aspirin-Induced; Peanut Hypersensitivity; Hypersensitivity, Immediate; Dermatitis, Atopic; Angioedema; Eczema; Hypersensitivity; Milk Hypersensitivity; Aspergillosis, Allergic Bronchopulmonary; Lichenoid Eruptions; Hypereosinophilic Syndrome; Gastrointestinal Diseases; Pruritus; Respiratory Sounds; Alopecia Areata; Chronic Urticaria; Nasal Polyps; Respiration Disorders; Eosinophilic gastroenteritis (EG); Respiratory Tract Diseases; Coronavirus Disease 2019 (COVID-19); Dermatitis; Prurigo Nodularis; Genetic Diseases, Inborn; Skin Diseases, Eczematous; Skin Diseases; Prostatic Neoplasms; Eosinophilic Esophagitis; Rhinitis, Allergic
Details
Berdazimer sodiumNVN-1000-SB-206-Novan; SB-206; MAP3-NONOate - SB-206; NVN1000-SB206; SB-019; NI-MC101; SB-207; SB-208; SB-204; SB-414ApprovedNovan IncZelsuvmi, ZELSUVMI, KINSOLUSTMUnited StatesMolluscum ContagiosumLnhc Inc2024-01-05Acne Vulgaris; Tinea Pedis; Psoriasis; Molluscum Contagiosum; Condylomata Acuminata; Dermatitis, Atopic
Details

Product Reviews

  • Y***G2025-11-07
    0People Like
    Initially used ACRO's TROP-2 protein with FC tag for animal immunization, the immunization effect is very satisfactory. Recently repurchased the his tag protein for antibody affinity detection, the obtained EC50 data is also very good, and the specificity is strong.
  • Z***N2025-11-07
    0People Like
    We purchased this IL-4 Protein mainly for characterization analysis and PK detection. The experimental results were good, method development was smooth, results met expectations, and the curves were good. Will repurchase if needed in the future.
  • M***e2023-06-15
    3People Like
    We have used this kit to profile compounds. This kit is both reliable and easy to use, and it shipped quickly. The 96 test kit is also amenable to scaling to a 384 well format for additional screening capabilities. In our experience, the customer service at ACRO has always been prompt when inquiring about when items will be restocked and when they have shipped.
  • Overview
  • Product List
  • Marketed Drug Information
  • Product Reviews
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland